Does eatin salmon protect against beta cell destruction in NIDDM? (diabetes stress diabetes mellitus pancreas insulin)
G'day G'day Folks,
One of the interesting side effects of differences of opinion is
that one retraces one's steps and in so doing comes across research
that one would otherwise miss.
Astaxanthin is a pretty pathetic antioxidant by some measures.
On the Trolox scale that gives Vit C and Vit E a value of 1.0, some
antioxidants such as quercetin values as high as 4.7. Astaxanthin
gets a measly 0.03
However it has some interesting properties in that it is reputed to
penetrate some tissues other antioxidants don't. Whether it
penetrates the brain barrier or not I don't know though it should be
easy enough to find out ... it is easy to identify since it is pink.
Derived from algae perhaps it is the reason salmon flesh is pink.
Whatever.
If it is AND this research on mice can be applied to humans then there
is good reason for T2 type diabetics (NIDDM) to eat salmon regularly.
Best wishes,
1: Redox Rep. 2002;7(5):290-3.
Astaxanthin protects beta-cells against glucose toxicity in diabetic
db/db mice.
Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T.
First Department of Medicine, Kyoto Prefectural University of
Medicine, Kyoto, Japan.
Oxidative stress induced by hyperglycemia possibly causes the
dysfunction of pancreatic beta-cells and various forms of tissue
damage in patients with diabetes mellitus. Astaxanthin, a carotenoid
of marine microalgae, is reported as a strong anti-oxidant inhibiting
lipid peroxidation and scavenging reactive oxygen species. The aim of
the present study was to examine whether astaxanthin can elicit
beneficial effects on the progressive destruction of pancreatic
beta-cells in db/db mice--a well-known obese model of type 2 diabetes.
We used diabetic C57BL/KsJ-db/db mice and db/m for the control.
Astaxanthin treatment was started at 6 weeks of age and its effects
were evaluated at 10, 14, and 18 weeks of age by non-fasting blood
glucose levels, int****ritoneal glucose tolerance test including
insulin secretion, and beta-cell histology. The non-fasting blood
glucose level in db/db mice was significantly higher than that of db/m
mice, and the higher level of blood glucose in db/db mice was
significantly decreased after treatment with astaxanthin. The ability
of islet cells to secrete insulin, as determined by the
int****ritoneal glucose tolerance test, was preserved in the
astaxanthin-treated group. Histology of the pancreas revealed no
significant differences in the beta-cell mass between
astaxanthin-treated and -untreated db/db mice.
In conclusion, these results indicate that astaxanthin can exert
beneficial effects in diabetes, with preservation of beta-cell
function.
This finding suggests that anti-oxidants may be potentially useful for
reducing glucose toxicity.
PMID: 12688512 [PubMed - indexed for MEDLINE]
--
Quentin Grady ^ ^ /
New Zealand, >#,#< [
/ \ /\
"... and the blind dog was leading."
http://homepages.paradise.net.nz/quentin
|